Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160054/S134

HeartMate 3 Left Ventricular Assist System

ABBOTT MEDICAL · Decision date Sep 9, 2026

MEDTECHLEDGER EXPLANATIONP160054/S134

What did the FDA decide?

The FDA database lists decision OK30 dated 2026-09-09 for P160054/S134, a 30-Day Notice filed by Abbott Medical under supplement reason Process Change - Manufacturer/Sterilizer/Packager/Supplier. The stated purpose is "adding an alternative supplier for the pump rotor subassembly" for the HeartMate 3 Left Ventricular Assist System, product code DSQ. The record does not name the supplier, describe the rotor subassembly's materials or dimensions, or specify which manufacturing step changes.

The supplement number ties this action to the original PMA P160054, but it does not approve the full system anew. The database describes a supplier addition on a component; it reports no clinical or performance data, so the entry is not independent evidence of safety or effectiveness. The word OK30 describes the decision status only, and the notice's stated purpose is separate from any conclusion about device performance.

FDA approval order statement

adding an alternative supplier for the pump rotor subassembly
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Sep 9, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P160054/S134
Regulatory pathway
PMA supplement
Product code
DSQ
Decision code
OK30
Decision date
Sep 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ventricular (assist) bypass.

Product code
DSQ
FDA device class
3

For the original device and its historical approval scope, see PMA P160054. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160054 · Original PMA

    HeartMate 3 Left Ventricular Assist System

  2. P160054/S134 received

    Application receipt date recorded by FDA.

  3. P160054/S134 · FDA decision

    30-Day Notice

  4. P160054/S136 · Related supplement

    HeartMate 3 Left Ventricular Assist System

Timeline entries are records held by MedtechLedger for P160054. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160054

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA approvalAug 23, 2017FDA
HeartMate 3 LVASP160054/S135
ABBOTT MEDICALPMA supplementOct 1, 2026FDA
ABBOTT MEDICALPMA supplementOct 19, 2026FDA

Explore the linked device profile

Other records with product code DSQ

Product / regulatory recordCompanyPathwayDecision dateSource
Berlin Heart, Inc.PMA supplementOct 30, 2026FDA
AbbottPMA supplementOct 30, 2026FDA
Berlin Heart, Inc.PMA supplementOct 28, 2026FDA
Berlin Heart, Inc.PMA supplementOct 23, 2026FDA
Berlin Heart, Inc.PMA supplementOct 14, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
6035 Stoneridge Dr., Pleasanton, CA, 94588

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records